Spruce Biosciences, Inc. (SPRB)
NASDAQ·Healthcare·Biotechnology
$49.54
+5.17%
Mkt Cap $36.05M
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
Implied Upside
+285.6%
Consensus $191.00 vs current $49.54
NASDAQ·Healthcare·Biotechnology
$49.54
+5.17%
Mkt Cap $36.05M
No recent rating data.
Price Target (6 analysts)
$191.00
Range $140.00 – $283.00
+285.6%
Consensus $191.00 vs current $49.54